Social Sentiment for AQXP
Bullish vs. Bearish opinions
Weighted Sentiment 0.00
Aquinox Pharmaceuticals Forecast and Stock Analysis
Technical AQXP stock analysis for Friday June 14, 2019.
Aquinox Pharmaceuticals gained 1.32% in the last trading day ( Friday, 14th Jun 2019 ), rising from $2.27 to $2.30 During day the stock fluctuated 3.12% from a day low at $2.24 to a day high of $2.31. The price has fallen in 7 of the last 10 days and is down by -11.88% for this period. Volume fell in the last day by -48 589 shares, and in total, 11 683 shares bought and sold for approximately $26 870.90. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the AQXP stock price was $2.74 and low was $2.19.
- 90 day high was $2.89 and low was $2.19.
- 52 week high for the Aquinox Pharmaceuticals - $16.14 and low - $1.96.
Aquinox Pharmaceuticals lies in the lower of a wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.26 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -9.38% during the next 3 months and, with 90% probability hold a price between $2.05 and $2.41 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday June 13, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aquinox Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.33 and $2.59. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 28 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
Aquinox Pharmaceuticals finds support from accumulated volume at $2.29.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.07 between high and low, or 3.12%. For the last week the stock has had a daily average volatility of 3.48%.
Aquinox Pharmaceuticals is oversold on RSI14 (28). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
3.48 %Average volatility
Very Low Low Medium High Very High
Aquinox Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|AQXP $2.30 ($0.03 1.32%)|
AQXP is up $0.03 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AQXP based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AQXP analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us